SERA PROGNOSTICS, INC.
SERA
DELAYED 1 MONTH
26 insider filings · Latest: Jun 9, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Jun 10 8:09 PM | Zhenya LindgardtDirector, Chief Executive Officer | Sale | 20,755 | $2.08 | $43.2K | 871,999(D) | View → |
| Jun 9, 2026 | Jun 10 8:08 PM | Austin AertsChief Financial Officer | Sale | 5,440 | $2.08 | $11.3K | 303,227(D) | View → |
| Jun 8, 2026 | Jun 9 8:10 PM | Sandra AJ LawrenceDirector | Sale | 1,560 | $2.15 | $3.4K | 16,473(D) | View → |
| Mar 11, 2026 | Mar 13 12:14 AM | Zhenya LindgardtDirector, Chief Executive Officer | Sale | 2,973 | $2.04 | $6.1K | 738,314(D) | View → |
| Mar 10, 2026 | Mar 13 12:14 AM | Zhenya LindgardtDirector, Chief Executive Officer | Sale | 22,639 | $1.90 | $43.0K | 741,287(D) | View → |
| Mar 11, 2026 | Mar 13 12:14 AM | Paul KearneyChief Data Officer | Sale | 1,396 | $2.04 | $2.8K | 163,961(D) | View → |
| Mar 11, 2026 | Mar 13 12:13 AM | Benjamin JacksonGeneral Counsel | Sale | 1,027 | $2.04 | $2.1K | 114,720(D) | View → |
| Mar 11, 2026 | Mar 13 12:12 AM | Robert Gardner HarrisonChief Information Officer | Sale | 716 | $2.04 | $1.5K | 76,712(D) | View → |
| Mar 11, 2026 | Mar 13 12:12 AM | John J. BonifaceChief Scientific Officer | Sale | 1,517 | $2.04 | $3.1K | 145,842(D) | View → |
| Mar 11, 2026 | Mar 13 12:12 AM | Austin AertsChief Financial Officer | Sale | 1,019 | $2.04 | $2.1K | 264,452(D) | View → |
| Mar 10, 2026 | Mar 13 12:12 AM | Austin AertsChief Financial Officer | Sale | 6,069 | $1.90 | $11.5K | 265,471(D) | View → |
| Mar 9, 2026 | Mar 10 9:54 PM | Paul KearneyChief Data Officer | Sale | 2,026 | $1.96 | $4.0K | 165,357(D) | View → |
| Mar 9, 2026 | Mar 10 9:53 PM | Benjamin JacksonGeneral Counsel | Sale | 3,119 | $1.96 | $6.1K | 115,747(D) | View → |
| Mar 9, 2026 | Mar 10 9:53 PM | Robert Gardner HarrisonChief Information Officer | Sale | 3,360 | $1.96 | $6.6K | 77,428(D) | View → |
| Mar 9, 2026 | Mar 10 9:53 PM | John J. BonifaceChief Scientific Officer | Sale | 3,038 | $1.96 | $6.0K | 147,359(D) | View → |
| Mar 9, 2026 | Mar 10 9:53 PM | Austin AertsChief Financial Officer | Sale | 674 | $1.96 | $1.3K | 271,540(D) | View → |
| Mar 6, 2026 | Mar 7 12:25 AM | Sandra AJ LawrenceDirector | Sale | 1,560 | $1.95 | $3.0K | 18,033(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Mar 13 10:28 PM | Zhenya LindgardtDirector, Chief Executive Officer | Grant/Award | 239,442 | $1.99 | 239,442(D) | View → |
| Mar 12, 2026 | Mar 13 10:28 PM | Benjamin JacksonGeneral Counsel | Grant/Award | 68,550 | $1.99 | 68,550(D) | View → |
| Mar 12, 2026 | Mar 13 10:28 PM | Tiffany Eul Davis InglisChief Medical Officer | Grant/Award | 27,034 | $1.99 | 27,034(D) | View → |
| Mar 12, 2026 | Mar 13 10:27 PM | Dyaarl Lee Anderson Jr.Chief Commercial Officer | Grant/Award | 19,310 | $1.99 | 19,310(D) | View → |
| Mar 12, 2026 | Mar 13 10:27 PM | Austin AertsChief Financial Officer | Grant/Award | 68,550 | $1.99 | 68,550(D) | View → |